This inventor holds 4 USPTO granted patents and 16 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Nls Pharma Ag, Assistance Publique-Hopitaux De Paris, Nls Pharmaceutics Ag. Active years: 2012-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Senlis, FR (2012 - 2019)
- Paris, FR (2020)
Company Filing History:
2 out of 2 
1 out of 331 
1 out of 3 Years Active: 2012-2020
Title: Eric Konofal: Innovator in ADHD Treatment
Introduction
Eric Konofal is a notable inventor based in Senlis, France. He has made significant contributions to the field of medicine, particularly in the treatment of attention deficit hyperactivity disorder (ADHD). With a total of 4 patents to his name, Konofal's work has the potential to impact the lives of many children suffering from this condition.
Latest Patents
Konofal's latest patents include innovative approaches to treating ADHD. One of his notable inventions is the use of iron for preparing a medicament aimed at the preventive and/or curative treatment of ADHD or its symptoms. This invention highlights the potential of iron in addressing the needs of patients requiring such treatment. Another significant patent is for Phacetoperane, which involves the treatment of ADHD with alpha-phenyl(piperidin-2-yl)methanol and its pharmaceutically acceptable salts and esters. This invention also includes methods for synthesizing the (S,S) enantiomer of alpha-phenyl(piperidin-2-yl)methanol and dextrophacetoperane.
Career Highlights
Throughout his career, Eric Konofal has worked with reputable organizations, including NLS Pharma AG and Assistance Publique-Hôpitaux de Paris. His experience in these institutions has contributed to his expertise in developing effective treatments for ADHD.
Collaborations
One of his notable collaborators is Bruno Figadere, with whom he has worked on various projects related to ADHD treatment.
Conclusion
Eric Konofal's innovative work in the field of ADHD treatment showcases his dedication to improving the lives of children affected by this disorder. His patents reflect a commitment to advancing medical science and providing effective solutions for those in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile